Brain scan breakthrough: amino acid PET may solve a tricky diagnosis dilemma
NCT ID NCT07676448
First seen Jun 30, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study tests whether a type of PET scan that tracks amino acids can accurately tell apart radiation necrosis (dead tissue from treatment) from tumor regrowth in people who have had radiation for brain metastases. About 80 patients who already received this PET scan will have their images analyzed. The goal is to see if the scan can give doctors a clear answer, avoiding unnecessary surgeries or wrong treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- amino acid PET scan
- What this could lead to
- If successful, this could give doctors a reliable way to tell whether a brain lesion is dead tissue or active cancer, guiding better treatment decisions.
- What could go wrong
- This is a small, early diagnostic study. The test may not be accurate enough in all patients, and results may not apply to everyone with brain metastases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a scan tell who needs more surgery after head and neck cancer?
- Can a 3D camera make brain radiation safer and more precise?
- Pinpoint radiation may spare the brain in lung cancer that spreads
- Spinal fluid DNA test could personalize brain cancer therapy
- Focused radiation doses put to the test for large brain tumors
- New PET scan targets hidden lung cancer cells